SESSION TITLE: Thrombosis Jamboree: Rare and Unique CasesSESSION TYPE: Rapid Fire Case ReportsPRESENTED ON: 10/19/2022 12:45 pm - 1:45 pmINTRODUCTION: A clot in transit is a rare clinical manifestation of venous thromboembolism (VTE), with an incidence of 3-18% in patients with acute pulmonary embolism (PE). It is defined as a mobile echogenic mass usually visualized in the right atrium or right ventricle using point of care ultrasound (POCUS). A clot in transit is associated with high morbidity and mortality and is deemed a medical emergency. This case report focuses on clot in transit and the role of POCUS in facilitating early intervention in submassive pulmonary embolism.CASE PRESENTATION: The patient is a 78-year-old male admitted to the acute inpatient rehabilitation unit after having an ischemic cerebrovascular accident two weeks prior. On Day 3 of admission, the patient suddenly developed altered mental status, hypotension that improved with fluids, intermittent supraventricular tachycardia , and new-onset hypoxia requiring transfer to the intensive care unit. POCUS revealed a mobile linear echogenic mass in the right atrium traversing the tricuspid valve into the right ventricle, consistent with a clot in transit. Evidence of right heart strain, suspicious for PE was seen. Labs were consistent with a submassive PE with elevated D-dimer, BNP, and troponin. Computed tomography of the chest with angiography (CTA) with PE protocol was not done due to a concomitant acute kidney injury. Therapeutic anticoagulation with heparin was initiated. After a review of the case by the multidisciplinary PE Response Team, the patient underwent percutaneous thrombectomy, with the extraction of emboli from both the right and left pulmonary arteries. After the procedure, there was an improvement in hemodynamics with an increased cardiac index (1.5 to 1.8) and decreased mean pulmonary artery pressure (36 mmHg to 23 mmHg). The patient significantly improved and was discharged on apixaban.DISCUSSION: A clot in transit is a rare finding in acute pulmonary embolism and is associated with increased mortality, as high as 45%, compared to PE alone. Although there are no established treatment guidelines due to the lack of prospective studies, a recent study showed that mortality was higher in patients treated with anticoagulation alone (36.4%) compared to thrombolysis (18.2%) or surgical embolectomy (18%). POCUS is an effective clinical modality that can be used to diagnose a clot in transit and promptly identify certain pathologies associated with acute PE, such as right heart strain. In this patient who could not undergo CTA, the gold standard to diagnose pulmonary embolism, POCUS was the sole diagnostic modality used to diagnose the VTE.CONCLUSIONS: The increasing use of POCUS as an initial screening tool to evaluate for causes of hemodynamic and respiratory compromise can lead to early identification of clot in transit in patients with pulmonary embolism and facilitate early intervention, ultimately leading to improved outcomes and decreased mortality.Reference #1: Garvey S, Dudzinski DM, Giordano N, Torrey J, Zheng H, Kabrhel C. Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes. Thromb Res. 2020 Mar;187:139-147.Reference #2: Burgos LM, Costabel JP, Brito VG, Sigal A, Maymo D, Iribarren A, Trivi M. Floating right heart thrombi: A pooled analysis of cases reported over the past 10 years. Am J Emerg Med. 2018 Jun; 36(6): 911-915.Reference #3: Shah DP, Min JK, Raman J, Lodato JA, Van Kley D, Lang RM, Ward RP. Thrombus-in-transit: two cases and a review of diagnosis and management. J Am Soc Echocardiogr. 2007 Oct;20(10):1219.e6-8.DISCLOSURES: Consultant relationship with Boehringer Ingelheim Please note: 8/10/2021 Added 03/31/2022 by Julia Budde, value=Consulting feeNo relevant relationships by Yasmin LeighNo relevant relationships by Racine Elaine ReinosoNo relevant relationships by James Thomas Salmon SESSION TITLE: Thrombosis Jamboree: Rare and Unique Cases SESSION TYPE: Rapid Fire Case Reports PRESENTED ON: 10/19/2022 12:45 pm - 1:45 pm INTRODUCTION: A clot in transit is a rare clinical manifestation of venous thromboembolism (VTE), with an incidence of 3-18% in patients with acute pulmonary embolism (PE). It is defined as a mobile echogenic mass usually visualized in the right atrium or right ventricle using point of care ultrasound (POCUS). A clot in transit is associated with high morbidity and mortality and is deemed a medical emergency. This case report focuses on clot in transit and the role of POCUS in facilitating early intervention in submassive pulmonary embolism. CASE PRESENTATION: The patient is a 78-year-old male admitted to the acute inpatient rehabilitation unit after having an ischemic cerebrovascular accident two weeks prior. On Day 3 of admission, the patient suddenly developed altered mental status, hypotension that improved with fluids, intermittent supraventricular tachycardia , and new-onset hypoxia requiring transfer to the intensive care unit. POCUS revealed a mobile linear echogenic mass in the right atrium traversing the tricuspid valve into the right ventricle, consistent with a clot in transit. Evidence of right heart strain, suspicious for PE was seen. Labs were consistent with a submassive PE with elevated D-dimer, BNP, and troponin. Computed tomography of the chest with angiography (CTA) with PE protocol was not done due to a concomitant acute kidney injury. Therapeutic anticoagulation with heparin was initiated. After a review of the case by the multidisciplinary PE Response Team, the patient underwent percutaneous thrombectomy, with the extraction of emboli from both the right and left pulmonary arteries. After the procedure, there was an improvement in hemodynamics with an increased cardiac index (1.5 to 1.8) and decreased mean pulmonary artery pressure (36 mmHg to 23 mmHg). The patient significantly improved and was discharged on apixaban. DISCUSSION: A clot in transit is a rare finding in acute pulmonary embolism and is associated with increased mortality, as high as 45%, compared to PE alone. Although there are no established treatment guidelines due to the lack of prospective studies, a recent study showed that mortality was higher in patients treated with anticoagulation alone (36.4%) compared to thrombolysis (18.2%) or surgical embolectomy (18%). POCUS is an effective clinical modality that can be used to diagnose a clot in transit and promptly identify certain pathologies associated with acute PE, such as right heart strain. In this patient who could not undergo CTA, the gold standard to diagnose pulmonary embolism, POCUS was the sole diagnostic modality used to diagnose the VTE. CONCLUSIONS: The increasing use of POCUS as an initial screening tool to evaluate for causes of hemodynamic and respiratory compromise can lead to early identification of clot in transit in patients with pulmonary embolism and facilitate early intervention, ultimately leading to improved outcomes and decreased mortality. Reference #1: Garvey S, Dudzinski DM, Giordano N, Torrey J, Zheng H, Kabrhel C. Pulmonary embolism with clot in transit: An analysis of risk factors and outcomes. Thromb Res. 2020 Mar;187:139-147. Reference #2: Burgos LM, Costabel JP, Brito VG, Sigal A, Maymo D, Iribarren A, Trivi M. Floating right heart thrombi: A pooled analysis of cases reported over the past 10 years. Am J Emerg Med. 2018 Jun; 36(6): 911-915. Reference #3: Shah DP, Min JK, Raman J, Lodato JA, Van Kley D, Lang RM, Ward RP. Thrombus-in-transit: two cases and a review of diagnosis and management. J Am Soc Echocardiogr. 2007 Oct;20(10):1219.e6-8. DISCLOSURES: Consultant relationship with Boehringer Ingelheim Please note: 8/10/2021 Added 03/31/2022 by Julia Budde, value=Consulting fee No relevant relationships by Yasmin Leigh No relevant relationships by Racine Elaine Reinoso No relevant relationships by James Thomas Salmon